ASTH · Astrana Health, Inc.
$40.81
+3.02 (+7.99%)
At close · Aug 14
Market Cap
$2.27B
Shares
55.74M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Brandon Sim | M.S. Chief Executive Officer | $14,930,231 |
| Dinesh Kumar | Chief Medical Officer | $4,283,715 |
| Chandan Basho | M.B.A. Chief Financial Officer and Chief Operating Officer | $3,867,057 |
| Kenneth Sim | Executive Chairman | $1,074,170 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Brandon Sim | M.S. Chief Executive Officer | $18,242,585 |
| Dinesh Kumar | Chief Medical Officer | $10,390,830 |
| Kenneth Sim | Executive Chairman | $10,362,866 |
| Chandan Basho | M.B.A. Chief Financial Officer and Chief Operating Officer | $5,460,490 |
| Thomas Lam | M.D., M.P.H. Vice Chairman (former Co-Chief Executive Officer) | $2,843,062 |
| Albert Young | M.D., M.P.H. SVP of Health Affairs (former Chief Administrative Officer) | $452,281 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Brandon Sim | M.S. Chief Executive Officer | $14,311,250 |
| Chandan Basho | M.B.A. Chief Financial Officer and Chief Operating Officer | $5,697,506 |
| Kenneth Sim | Executive Chairman | $5,223,600 |
| Thomas Lam | M.D., M.P.H. Vice Chairman (former Co-Chief Executive Officer) | $5,217,562 |
| Albert Young | M.D., M.P.H. SVP of Health Affairs (former Chief Administrative Officer) | $562,773 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Brandon Sim | M.S. Chief Executive Officer | $15,302,775 |
| Chandan Basho | M.B.A. Chief Financial Officer and Chief Operating Officer | $4,103,227 |
| Kenneth Sim | Executive Chairman | $1,494,015 |
| Thomas Lam | M.D., M.P.H. Vice Chairman (former Co-Chief Executive Officer) | $1,487,709 |
| Albert Young | M.D., M.P.H. SVP of Health Affairs (former Chief Administrative Officer) | $573,673 |
| Eric Chin | Chief Financial Officer and Corporate Secretary | $498,491 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Brandon Sim | Co-Chief Executive Officer | $9,006,157 |
| Kenneth Sim | Executive Chairman | $6,863,527 |
| Thomas Lam | M.D., M.P.H. Co-Chief Executive Officer and President | $6,857,194 |
| Eric Chin | Chief Financial Officer and Corporate Secretary | $822,892 |
| Chief Administrative | Officer | $453,726 |
| Albert Young | M.D., M.P.H. | $453,726 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Kenneth Sim | Executive Chairman | $2,521,773 |
| Thomas Lam | M.D., M.P.H. Co-Chief Executive Officer and President | $2,515,142 |
| Brandon Sim | Co-Chief Executive Officer | $1,446,731 |
| Eric Chin | Chief Financial Officer and Corporate Secretary | $499,230 |
| Adrian Vazquez | Chief Medical Officer | $479,080 |
| Chief Administrative | Officer | $416,648 |
| Albert Young | M.D., M.P.H. | $416,648 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Kenneth Sim | Executive Chairman | $2,495,730 |
| Thomas Lam | M.D., M.P.H. Co-Chief Executive Officer and President | $2,489,144 |
| Adrian Vazquez | Chief Medical Officer | $517,062 |
| Eric Chin | Chief Financial Officer and Corporate Secretary | $456,577 |
| Chief Administrative | Officer | $381,413 |
| Albert Young | Chief Administrative Officer | $381,413 |
| Hing Ang | Chief Operating Officer | $349,253 |
| Brandon Sim | Co-Chief Executive Officer | $73,099 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Hing Ang | Chief Operating Officer | $1,556,621 |
| Kenneth Sim | Executive Chairman and Co-Chief Executive Officer | $971,346 |
| Thomas Lam | M.D., M.P.H. Co-Chief Executive Officer and President | $964,841 |
| Adrian Vazquez | Chief Medical Officer | $482,111 |
| Albert Young | Chief Administrative Officer | $346,286 |
| Chief Administrative | Officer | $346,286 |
| Eric Chin | Chief Financial Officer and Corporate Secretary | $260,769 |
| Brandon Sim | Chief Operating Officer and Chief Technology Officer | — |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Kenneth Sim | Executive Chairman and Co-Chief Executive Officer | $857,141 |
| Thomas Lam | Co-Chief Executive Officer and President | $846,189 |
| Adrian Vazquez | Chief Medical Officer | $698,374 |
| Hing Ang | Chief Operating Officer | $482,683 |
| Albert Young | Chief Administrative Officer | $439,139 |
| Eric Chin | Chief Financial Officer and Corporate Secretary | — |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| John Vong | principal accounting officer | Appointed | 2026-07-01 |
| Glenn Sobotka | Chief Accounting Officer and principal accounting officer | Retired | 2026-07-01 |
| David G. Schmidt | Director | Appointed | 2026-06-10 |
| Matthew Mazdyasni | Director | Appointed | 2026-06-10 |
| Mitchell W. Kitayama | Director | Appointed | 2026-06-10 |
| J. Lorraine Estradas, R.N., B.S.N. M.P.H. | Director | Appointed | 2026-06-10 |
| Linda Dong | Director | Appointed | 2026-06-10 |
| Weili Dai | Director | Appointed | 2026-06-10 |
| John Chiang | Director | Appointed | 2026-06-10 |
| Thomas S. Lam, M.D., M.P.H. | Director | Appointed | 2026-06-10 |
| Kenneth Sim, M.D. | Director | Appointed | 2026-06-10 |
| Dinesh Kumar, M.D. | Chief Medical Officer | Resigned | 2026-05-12 |
| Glenn W. Sobotka | Chief Accounting Officer and principal accounting officer | Appointed | 2025-03-28 |
| Chandan Basho | Chief Financial Officer and Chief Operating Officer | Appointed | 2024-01-24 |
| Brandon Sim | Chief Executive Officer and President | Appointed | 2024-01-24 |
| Thomas S. Lam, M.D., M.P.H. | Vice Chairman of the Board | Appointed | 2024-01-24 |
| Weili Dai | Director | Appointed | 2023-06-16 |
| Matthew Mazdyasni | Director | Appointed | 2023-06-16 |
| J. Lorraine Estradas, R.N., B.S.N. M.P.H. | Director | Appointed | 2023-06-16 |
| John Chiang | Director | Appointed | 2023-06-16 |
| Linda Marsh | Director | Appointed | 2023-06-16 |
| David G. Schmidt | Director | Appointed | 2023-06-16 |
| Mitchell W. Kitayama | Director | Appointed | 2023-06-16 |
| Thomas S. Lam, M.D., M.P.H. | Director | Appointed | 2023-06-16 |
| Kenneth Sim, M.D. | Director | Appointed | 2023-06-16 |
Key facts
CIK
1083446
CUSIP
03763A207
13F (30d)
194 filings
193 filers
Visit website
Investor relations